Want to see BNBX full AI Analyst Report?
BNBX Stock Chart & Stats
$0.13
<$0.01(5.92%)
At close: 4:00 PM EDT
$0.13
<$0.01(5.92%)
Day’s Range― - ―
52-Week Range$0.07 - $3.87
Previous CloseN/A
Volume2.78K
Average Volume (3M)22.02K
Market Cap
$570.76K
Enterprise Value$2.64M
Total Cash (Recent Filing)$949.09K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.39
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,197,223
10 Day Avg. Volume24,310
30 Day Avg. Volume22,016
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.87
Price to Sales (P/S)0.94
P/FCF Ratio-0.16
Enterprise Value/Market Cap4.63
Enterprise Value/Revenue1.26
Enterprise Value/Gross Profit2.91
Enterprise Value/Ebitda-0.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe sharp TTM revenue rebound indicates that the company has demonstrated some ability to expand its top line. If this growth can be sustained and converted into healthier margins, it could improve operating leverage, support reinvestment, and strengthen the business over the next several quarters.
Low LeverageMinimal debt reduces financial risk and limits the burden of interest or refinancing obligations while the company pursues its transition. The stronger equity base also provides more asset support, giving management greater flexibility to fund operations and restructure the business.
Strategic Operating PivotMoving from a passive digital-asset treasury toward infrastructure for institutional blockchain and agentic AI use could create a more service-oriented operating model. A focus on secure, compliant enterprise deployment may provide a clearer route to recurring commercial activity than asset exposure alone.
Bears Say
Severe UnprofitabilityThe revenue rebound has not translated into earnings power: gross profitability remains low and operating and net losses are exceptionally large relative to sales. This indicates an outsized cost structure, making durable profitability dependent on substantial margin improvement or major operating changes.
Persistent Cash BurnDeeply negative operating and free cash flow show that the business is consuming substantial cash rather than funding itself internally. Continued cash burn can create recurring financing needs and constrain investment capacity, especially if the revenue recovery does not improve cash conversion.
Execution And Governance UncertaintyThe strategic transition is accompanied by meaningful governance change and stronger ties to investor-affiliated infrastructure entities. Board turnover and evolving capital relationships may complicate execution, oversight, and accountability while management attempts to establish the new operating model.
BNB Plus News
BNBX FAQ
What was BNB Plus’s price range in the past 12 months?
BNB Plus lowest stock price was $0.07 and its highest was $3.87 in the past 12 months.
What is BNB Plus’s market cap?
BNB Plus’s market cap is $570.76K.
When is BNB Plus’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BNB Plus’s earnings last quarter?
Currently, no data Available
Is BNB Plus overvalued?
According to Wall Street analysts BNB Plus’s price is currently Overvalued.
Does BNB Plus pay dividends?
BNB Plus does not currently pay dividends.
What is BNB Plus’s EPS estimate?
BNB Plus’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BNB Plus have?
BNB Plus has 6,197,223 shares outstanding.
What happened to BNB Plus’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BNB Plus?
Currently, no hedge funds are holding shares in BNBX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BNB Plus
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Technical Analysis
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
iSpecimen
―
BioNexus Gene Lab Corp
―
―
Ownership Overview
2.36% Insiders
0.48% Mutual Funds
<0.01% Other Institutional Investors
97.16% Public Companies and
Individual Investors